HR7853-119

In Committee

PrEP Access and Coverage Act of 2026

119th Congress Introduced Mar 5, 2026

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, PrEP Access and Coverage Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Social Welfare.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H6FB34EA2A83B47EB8DC2DBAE7A8771AA: 1. Short title This Act may be cited as the PrEP Access and Coverage Act of 2026.
  • Section H84FB657B3D0E496F8FB9A5865DF61BCF: 2. Sense of Congress It is the sense of Congress that the Department of Labor, the Department of Health and Human Services, and the Department of the Treasury...
  • Section HCBDE13915BDC4CD18E996155A4F8D01B: 3. Coverage requirements Section 2713(a) of the Public Health Service Act (42 U.S.C. 300gg–13(a)) is amended— in paragraph (2), by striking ; and and inserting...
  • Section H8EF73D7132D4409EAFC68FC3A1E59E98: 2799A–12. Prohibition on preauthorization requirements with respect to certain services A group health plan or a health insurance issuer offering group or...
  • Section H78ECB6293F064185A1FF897FF06087B0: 727. Prohibition on preauthorization requirements with respect to certain services A group health plan or a health insurance issuer offering group health...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, PrEP Access and Coverage Act of 2026, changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Government Operations, Social Welfare

Primary Purpose

This bill, PrEP Access and Coverage Act of 2026, changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Government Operations Social Welfare

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

In Committee
Introduced Committee Passed
Mar 5, 2026

Referred to the Committee on Energy and Commerce, and in …

Mar 5, 2026

Introduced in House

Mar 5, 2026

Mr. Takano (for himself, Mr. Pocan, and Ms. Balint) introduced …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Government Operations Social Welfare
Actor Mappings
"the_commission"
→ The commission identified in the operative section
"the_administrator"
→ The Administrator identified in the operative section
"secretary_of_labor"
→ Secretary of Labor
"secretary_of_defense"
→ Secretary of Defense
"secretary_of_treasury"
→ Secretary of the Treasury
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

Key Definitions

Terms defined in this bill

2 terms
"PEP" §H5E4729F79F244B4080DE4E47725CC72A

any drug or combination of drugs approved by the Food and Drug Administration for preventing HIV transmission after a sexual or other exposure associated with a high risk of HIV transmission

"PEP" §HF259FBF3C2994FEBA3D0200E72E21202

any drug or combination of drugs approved by the Food and Drug Administration for preventing HIV transmission after a sexual or other exposure associated with a high risk of HIV transmission

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology